Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Premkumar Reddy

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Pharmaceutical Research|June 9, 2012
Preclinical pharmacokinetic and pharmacodynamic evaluation of novel anticancer agents, ON01910.Na (Rigosertib, Estybon™) and ON013105, for brain tumor chemotherapySilpa Nuthalapati, Qingyu Zhou, Ping Guo, et al.
Bioorganic & Medicinal Chemistry|February 9, 2005
Design, synthesis, and biological evaluation of (E)- and (Z)-styryl-2-acetoxyphenyl sulfides and sulfones as cyclooxygenase-2 inhibitorsM V Ramana Reddy, Muralidhar Reddy Mallireddigari, Venkat R Pallela, et al.
The Journal of Cell Biology|November 1, 2006
Activation of p38alpha/beta MAPK in myogenesis via binding of the scaffold protein JLP to the cell surface protein CdoGiichi Takaesu, Jong-Sun Kang, Gyu-Un Bae, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Synthesis of new coumarin 3-(N-aryl) sulfonamides and their anticancer activityNatala Srinivasa Reddy, Muralidhar Reddy Mallireddigari, Stephen Cosenza, et al.
The Journal of Biological Chemistry|October 16, 2015
JNK-associated Leucine Zipper Protein Functions as a Docking Platform for Polo-like Kinase 1 and Regulation of the Associating Transcription Factor Forkhead Box Protein K1Poornima Ramkumar, Clement M Lee, Annie Moradian, et al.
Molecular Cancer Therapeutics|February 27, 2014
Preclinical pharmacological evaluation of a novel multiple kinase inhibitor, ON123300, in brain tumor modelsXiaoping Zhang, Hua Lv, Qingyu Zhou, et al.
Bioorganic & Medicinal Chemistry|February 15, 2008
Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitorsM V Ramana Reddy, Vinay K Billa, Venkat R Pallela, et al.
Journal of Biochemistry|February 15, 2015
Identification and characterization of a cell division-regulating kinase AKB1 (associated kinase of Trypanosoma brucei 14-3-3) through proteomics study of the Tb14-3-3 binding proteinsMasahiro Inoue, Kenta Okamoto, Haruki Uemura, et al.
Organic & Biomolecular Chemistry|February 7, 2013
Hydrothiolation of benzyl mercaptan to arylacetylene: application to the synthesis of (E) and (Z)-isomers of ON 01910·Na (Rigosertib®), a phase III clinical stage anti-cancer agentVenkat R Pallela, Muralidhar R Mallireddigari, Stephen C Cosenza, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2005
A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistanceKiranmai Gumireddy, Stacey J Baker, Stephen C Cosenza, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Pharmaceutical Research|June 9, 2012
Preclinical pharmacokinetic and pharmacodynamic evaluation of novel anticancer agents, ON01910.Na (Rigosertib, Estybon™) and ON013105, for brain tumor chemotherapySilpa Nuthalapati, Qingyu Zhou, Ping Guo, et al.
Bioorganic & Medicinal Chemistry|February 9, 2005
Design, synthesis, and biological evaluation of (E)- and (Z)-styryl-2-acetoxyphenyl sulfides and sulfones as cyclooxygenase-2 inhibitorsM V Ramana Reddy, Muralidhar Reddy Mallireddigari, Venkat R Pallela, et al.
The Journal of Cell Biology|November 1, 2006
Activation of p38alpha/beta MAPK in myogenesis via binding of the scaffold protein JLP to the cell surface protein CdoGiichi Takaesu, Jong-Sun Kang, Gyu-Un Bae, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Synthesis of new coumarin 3-(N-aryl) sulfonamides and their anticancer activityNatala Srinivasa Reddy, Muralidhar Reddy Mallireddigari, Stephen Cosenza, et al.
The Journal of Biological Chemistry|October 16, 2015
JNK-associated Leucine Zipper Protein Functions as a Docking Platform for Polo-like Kinase 1 and Regulation of the Associating Transcription Factor Forkhead Box Protein K1Poornima Ramkumar, Clement M Lee, Annie Moradian, et al.
Molecular Cancer Therapeutics|February 27, 2014
Preclinical pharmacological evaluation of a novel multiple kinase inhibitor, ON123300, in brain tumor modelsXiaoping Zhang, Hua Lv, Qingyu Zhou, et al.
Bioorganic & Medicinal Chemistry|February 15, 2008
Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitorsM V Ramana Reddy, Vinay K Billa, Venkat R Pallela, et al.
Journal of Biochemistry|February 15, 2015
Identification and characterization of a cell division-regulating kinase AKB1 (associated kinase of Trypanosoma brucei 14-3-3) through proteomics study of the Tb14-3-3 binding proteinsMasahiro Inoue, Kenta Okamoto, Haruki Uemura, et al.
Organic & Biomolecular Chemistry|February 7, 2013
Hydrothiolation of benzyl mercaptan to arylacetylene: application to the synthesis of (E) and (Z)-isomers of ON 01910·Na (Rigosertib®), a phase III clinical stage anti-cancer agentVenkat R Pallela, Muralidhar R Mallireddigari, Stephen C Cosenza, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2005
A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistanceKiranmai Gumireddy, Stacey J Baker, Stephen C Cosenza, et al.
Pageof 10